Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06418711
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2024-05-08
Brief Title:
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101 Clofazimine Inhalation Suspension
Sponsor:
Mannkind Corporation
Organization:
Mannkind Corporation
Organization Data
Organization:
Mannkind Corporation
Class:
INDUSTRY
Study ID:
MKC-CI-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mannkind Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None